Cell scientist to watch - Mads Gyrd-Hansen

Research output: Contribution to journalComment/debateResearch

Standard

Cell scientist to watch - Mads Gyrd-Hansen. / Gyrd-Hansen, Mads.

In: Journal of Cell Science, Vol. 130, No. 12, 2017, p. 1981-1983.

Research output: Contribution to journalComment/debateResearch

Harvard

Gyrd-Hansen, M 2017, 'Cell scientist to watch - Mads Gyrd-Hansen', Journal of Cell Science, vol. 130, no. 12, pp. 1981-1983. https://doi.org/10.1242/jcs.205401

APA

Gyrd-Hansen, M. (2017). Cell scientist to watch - Mads Gyrd-Hansen. Journal of Cell Science, 130(12), 1981-1983. https://doi.org/10.1242/jcs.205401

Vancouver

Gyrd-Hansen M. Cell scientist to watch - Mads Gyrd-Hansen. Journal of Cell Science. 2017;130(12):1981-1983. https://doi.org/10.1242/jcs.205401

Author

Gyrd-Hansen, Mads. / Cell scientist to watch - Mads Gyrd-Hansen. In: Journal of Cell Science. 2017 ; Vol. 130, No. 12. pp. 1981-1983.

Bibtex

@article{8c093caf23ef4509952038b90d9d3843,
title = "Cell scientist to watch - Mads Gyrd-Hansen",
abstract = "Mads Gyrd-Hansen studied biochemistry at the University of Copenhagen and received his PhD in 2005 under the supervision of Marja J{\"a}{\"a}ttel{\"a}at the Danish Cancer Society Research Centre. He then joined the laboratory of Pascal Meier at the Institute of Cancer Research in London to work on the inhibitor of apoptosis (IAP) proteins. Mads returned to Copenhagen in 2008 to the Biotech Research and Innovation Centre (BRIC) in a senior postdoctoral position with Morten Fr{\"o}din, and subsequently started his own research group with a career-development fellowship from the Danish Research Councils as part of the laboratory of Niels Mailand at the Novo Nordisk Foundation Centre for Protein Research. In 2013, he joined the Ludwig Institute for Cancer Research at the University of Oxford, where he is now an associate professor and holder of a Wellcome Trust Senior Research Fellowship and a Sapere Aude starting grant from the Danish Research Councils. Mads is interested in the non-degradative functions and regulation of ubiquitylation in pro-inflammatory signalling during innate immune responses.",
author = "Mads Gyrd-Hansen",
note = "Publisher Copyright: {\textcopyright} 2017. Published by The Company of Biologists Ltd.",
year = "2017",
doi = "10.1242/jcs.205401",
language = "English",
volume = "130",
pages = "1981--1983",
journal = "Journal of Cell Science",
issn = "0021-9533",
publisher = "The/Company of Biologists Ltd.",
number = "12",

}

RIS

TY - JOUR

T1 - Cell scientist to watch - Mads Gyrd-Hansen

AU - Gyrd-Hansen, Mads

N1 - Publisher Copyright: © 2017. Published by The Company of Biologists Ltd.

PY - 2017

Y1 - 2017

N2 - Mads Gyrd-Hansen studied biochemistry at the University of Copenhagen and received his PhD in 2005 under the supervision of Marja Jäätteläat the Danish Cancer Society Research Centre. He then joined the laboratory of Pascal Meier at the Institute of Cancer Research in London to work on the inhibitor of apoptosis (IAP) proteins. Mads returned to Copenhagen in 2008 to the Biotech Research and Innovation Centre (BRIC) in a senior postdoctoral position with Morten Frödin, and subsequently started his own research group with a career-development fellowship from the Danish Research Councils as part of the laboratory of Niels Mailand at the Novo Nordisk Foundation Centre for Protein Research. In 2013, he joined the Ludwig Institute for Cancer Research at the University of Oxford, where he is now an associate professor and holder of a Wellcome Trust Senior Research Fellowship and a Sapere Aude starting grant from the Danish Research Councils. Mads is interested in the non-degradative functions and regulation of ubiquitylation in pro-inflammatory signalling during innate immune responses.

AB - Mads Gyrd-Hansen studied biochemistry at the University of Copenhagen and received his PhD in 2005 under the supervision of Marja Jäätteläat the Danish Cancer Society Research Centre. He then joined the laboratory of Pascal Meier at the Institute of Cancer Research in London to work on the inhibitor of apoptosis (IAP) proteins. Mads returned to Copenhagen in 2008 to the Biotech Research and Innovation Centre (BRIC) in a senior postdoctoral position with Morten Frödin, and subsequently started his own research group with a career-development fellowship from the Danish Research Councils as part of the laboratory of Niels Mailand at the Novo Nordisk Foundation Centre for Protein Research. In 2013, he joined the Ludwig Institute for Cancer Research at the University of Oxford, where he is now an associate professor and holder of a Wellcome Trust Senior Research Fellowship and a Sapere Aude starting grant from the Danish Research Councils. Mads is interested in the non-degradative functions and regulation of ubiquitylation in pro-inflammatory signalling during innate immune responses.

U2 - 10.1242/jcs.205401

DO - 10.1242/jcs.205401

M3 - Comment/debate

AN - SCOPUS:85020507636

VL - 130

SP - 1981

EP - 1983

JO - Journal of Cell Science

JF - Journal of Cell Science

SN - 0021-9533

IS - 12

ER -

ID: 303722927